MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest income
$18,355K
(-9.50%↓ Y/Y)
Other gains
(expenses)
$29K
Net loss
-$265,939K
(-37.43%↓ Y/Y)
Total other income
(expense), net
$4,078K
(118.77%↑ Y/Y)
Product
$51,823K
Collaboration Revenue
$128K
Interest expense
$11,835K
(-12.83%↓ Y/Y)
Change in fair value of
derivative liabilities
-$2,471K
(-414.79%↓ Y/Y)
Loss from operations
-$270,017K
(-57.19%↓ Y/Y)
Total revenue, net
$51,951K
(-18.14%↓ Y/Y)
Total costs and
operating expenses
$321,968K
(36.71%↑ Y/Y)
Research and development
$197,096K
(54.42%↑ Y/Y)
General and
administrative
$64,376K
(6.14%↑ Y/Y)
Selling and marketing
$53,922K
(29.65%↑ Y/Y)
Cost of product
revenue
$6,574K
(16.85%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
OCULAR THERAPEUTIX, INC (OCUL)
OCULAR THERAPEUTIX, INC (OCUL)